eCite Digital Repository

Innovation in medical biotechnology: Mapping the intersection of intellectual property and competition law

Citation

Nielsen, JL, Innovation in medical biotechnology: Mapping the intersection of intellectual property and competition law, Australian Business Law Review, 35, (6) pp. 407-433. ISSN 0310-1053 (2007) [Refereed Article]


Preview
PDF
Restricted - Request a copy
209Kb
  

Official URL: http://www.thomsonreuters.com.au/

Abstract

Intellectual property and competition law are often perceived as being in conflict. This is evidenced by a lengthy struggle to identify an appropriate balance between these areas of law. While it is generally recognised that the two bodies of law are reconcilable, areas of difficulty persist. New technologies have given rise to novel challenges at the intersection of intellectual property and competition law. One industry that possesses the distinctive traits of a high technology industry is medical biotechnology. This industry is highly innovative and, increasingly, industry participants are seeking to commercialise their research results through patenting. This has resulted in an industry that relies heavily on patent protection. This article seeks to consider in broad terms the role that competition law should have in promoting innovation in medical biotechnology, and how this role should be reconciled with the function of patents in this industry.

Item Details

Item Type:Refereed Article
Research Division:Law and Legal Studies
Research Group:Law
Research Field:Law not elsewhere classified
Objective Division:Law, Politics and Community Services
Objective Group:Justice and the Law
Objective Field:Justice and the Law not elsewhere classified
Author:Nielsen, JL (Dr Jane Nielsen)
ID Code:49560
Year Published:2007
Deposited By:Law
Deposited On:2007-08-01
Last Modified:2009-07-13
Downloads:8 View Download Statistics

Repository Staff Only: item control page